| Toll-like receptor 4 polymorphisms and atherogenesis S Kiechl, E Lorenz, M Reindl, CJ Wiedermann, F Oberhollenzer, E Bonora, ... New England Journal of Medicine 347 (3), 185-192, 2002 | 1433 | 2002 |
| Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study S Kiechl, G Egger, M Mayr, CJ Wiedermann, E Bonora, F Oberhollenzer, ... Circulation 103 (8), 1064-1070, 2001 | 744 | 2001 |
| Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study CJ Wiedermann, S Kiechl, S Dunzendorfer, P Schratzberger, G Egger, ... Journal of the American College of Cardiology 34 (7), 1975-1981, 1999 | 615 | 1999 |
| Lipoprotein-associated phospholipase A (2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. A Thompson, P Gao, L Orfei, S Watson, E Di Angelantonio, S Kaptoge, ... Lancet (London, England) 375 (9725), 1536-1544, 2010 | 593 | 2010 |
| Treatment effects of high‐dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation J Kienast, M Juers, CJ Wiedermann, JN Hoffmann, H Ostermann, ... Journal of Thrombosis and Haemostasis 4 (1), 90-97, 2006 | 446 | 2006 |
| Oxidized phospholipids, lipoprotein (a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study S Kiechl, J Willeit, M Mayr, B Viehweider, M Oberhollenzer, F Kronenberg, ... Arteriosclerosis, thrombosis, and vascular biology 27 (8), 1788-1795, 2007 | 322 | 2007 |
| Antithrombin: a new look at the actions of a serine protease inhibitor J Roemisch, E Gray, JN Hoffmann, CJ Wiedermann Blood coagulation & fibrinolysis 13 (8), 657-670, 2002 | 296 | 2002 |
| Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies CJ Wiedermann, W Wiedermann, M Joannidis Intensive care medicine 36, 1657-1665, 2010 | 293 | 2010 |
| Increased expression of CCL20 in human inflammatory bowel disease A Kaser, O Ludwiczek, S Holzmann, AR Moschen, G Weiss, B Enrich, ... Journal of clinical immunology 24, 74-85, 2004 | 250 | 2004 |
| High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety CJ Wiedermann, JN Hoffmann, M Juers, H Ostermann, J Kienast, ... Critical care medicine 34 (2), 285-292, 2006 | 244 | 2006 |
| Expression and function of the endothelial protein C receptor in human neutrophils DH Sturn, NC Kaneider, C Feistritzer, A Djanani, K Fukudome, ... Blood 102 (4), 1499-1505, 2003 | 241 | 2003 |
| Hypoalbuminemia as surrogate and culprit of infections CJ Wiedermann International journal of molecular sciences 22 (9), 4496, 2021 | 225 | 2021 |
| Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis SJ Klein, AK Brandtner, GF Lehner, H Ulmer, SM Bagshaw, ... Intensive care medicine 44, 323-336, 2018 | 193 | 2018 |
| Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials CJ Wiedermann, S Dunzendorfer, LU Gaioni, F Zaraca, M Joannidis Critical Care 14, 1-9, 2010 | 193 | 2010 |
| Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study S Tsimikas, J Willeit, M Knoflach, M Mayr, G Egger, M Notdurfter, ... European heart journal 30 (1), 107-115, 2009 | 193 | 2009 |
| Migration of human monocytes in response to procalcitonin FJ Wiedermann, N Kaneider, P Egger, W Tiefenthaler, CJ Wiedermann, ... Critical care medicine 30 (5), 1112-1117, 2002 | 178 | 2002 |
| Fluid management in sepsis: The potential beneficial effects of albumin JL Vincent, D De Backer, CJ Wiedermann Journal of critical care 35, 161-167, 2016 | 151 | 2016 |
| Induction of circulating IL-1 receptor antagonist by IFN treatment. H Tilg, JW Mier, W Vogel, WE Aulitzky, CJ Wiedermann, E Vannier, ... Journal of immunology (Baltimore, Md.: 1950) 150 (10), 4687-4692, 1993 | 149 | 1993 |
| Marburg I polymorphism of factor VII–activating protease: a prominent risk predictor of carotid stenosis J Willeit, S Kiechl, T Weimer, A Mair, P Santer, CJ Wiedermann, ... Circulation 107 (5), 667-670, 2003 | 145 | 2003 |
| Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. P Schratzberger, N Reinisch, WM Prodinger, CM Kähler, BA Sitte, ... Journal of immunology (Baltimore, Md.: 1950) 158 (8), 3895-3901, 1997 | 144 | 1997 |
Herbert TilgUniv.-Prof. Dr.在 i-med.ac.at 的电子邮件经过验证